SCHEMBL7707876

SCHEMBL7707876

COc1ccc(CN2C(=O)NC(c3ccc(F)c(F)c3)c3ccccc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.48
TP53 P04637 1/20 0.48
THRB P10828 1/20 0.48
ALDH1A1 P00352 3/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
GSK3B P49841 3/20 0.44
MAPT P10636 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ADK P55263 1/20 0.42
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
LMNA P02545 1/20 0.41
CMA1 P23946 1/20 0.41
GPR55 Q9Y2T6 1/20 0.40
CASP3 P42574 1/20 0.40
GSK3A P49840 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29071974 0.76 CMA1 (0.47) SMN1; SMN2TP53THRBALDH1A1GSK3B
SCHEMBL16108507 0.72 ALDH1A1 (0.52) SMN1; SMN2TP53THRBALDH1A1CYP3A4
SCHEMBL11725270 0.68 LMNA (0.41) SMN1; SMN2ALDH1A1CYP3A4CYP2D6CYP2C9
SCHEMBL6668852 0.66 L3MBTL1 (0.56) ALDH1A1GSK3BMAPTL3MBTL1ADK
SCHEMBL19410712 0.66 GSK3B (0.53) GSK3BL3MBTL1ADKMEN1KMT2A
SCHEMBL15973495 0.66 TNF (0.53) GSK3BL3MBTL1MEN1KMT2ACMA1
SCHEMBL11468063 0.66 PDE6D (0.42) SMN1; SMN2ALDH1A1CYP3A4CYP2D6CYP2C19
SCHEMBL13793156 0.66 TNF (0.47) ALDH1A1GSK3BMAPTL3MBTL1MEN1
SCHEMBL11472434 0.65 LMNA (0.44) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL23536455 0.65 GSK3B (0.67) SMN1; SMN2TP53ALDH1A1GSK3BMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358959-B1 FOR THERAPY OF BENIGN PROSTATIC HYPERPLASIA MERCK & CO., INC. 2002-03-19 US disclosed
WO-2000043374-A1 POLYAZANAPHTHALENONE DERIVATIVES USEFUL AS ALPHA 1A ADRENOCEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2000-07-27 WO disclosed